Cargando…
Mechanistic Investigations Support Liver Safety of Ubrogepant
Small-molecule calcitonin gene-related peptide (CGRP) receptor antagonists have demonstrated therapeutic efficacy for the treatment of migraine. However, previously investigated CGRP receptor antagonists, telcagepant and MK-3207, were discontinued during clinical development because of concerns abou...
Autores principales: | Smith, Brenda, Rowe, Josh, Watkins, Paul B, Ashina, Messoud, Woodhead, Jeffrey L, Sistare, Frank D, Goadsby, Peter J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312697/ https://www.ncbi.nlm.nih.gov/pubmed/32579200 http://dx.doi.org/10.1093/toxsci/kfaa093 |
Ejemplares similares
-
Evaluation of the Pharmacokinetic Interaction of Ubrogepant Coadministered With Sumatriptan and of the Safety of Ubrogepant With Triptans
por: Jakate, Abhijeet, et al.
Publicado: (2020) -
Nonclinical Safety Assessment of AMG 553, an Investigational Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Acute Myeloid Leukemia
por: Karbowski, Christine, et al.
Publicado: (2020) -
Role of neurotoxicants in the pathogenesis of Alzheimer’s disease: a mechanistic insight
por: Nisa, Fatema Yasmin, et al.
Publicado: (2021) -
Beyond AOPs: A Mechanistic Evaluation of NAMs in DART Testing
por: Rajagopal, Ramya, et al.
Publicado: (2022) -
Toxicological impact of microplastics and nanoplastics on humans: understanding the mechanistic aspect of the interaction
por: Alqahtani, Saeed, et al.
Publicado: (2023)